Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort
2 other identifiers
observational
20
1 country
1
Brief Summary
This is a prospective, observational cohort study of pediatric patients ages 2-12 undergoing radiation therapy at MD Anderson Cancer Center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
Study Completion
Last participant's last visit for all outcomes
March 1, 2029
May 8, 2026
May 1, 2026
5 months
May 4, 2026
May 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Through study completion; an average of 1 year.
Eligibility Criteria
UT MD Anderson patients
You may qualify if:
- To be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent from a parent or legal guardian.
- For children age 7 and older, provision of informed assent in addition to parental consent, consistent with institutional guidelines.
- Stated willingness of parent/guardian and child (as appropriate) to comply with study procedures (i.e., observation during scheduled radiation therapy appointments).
- Male or female, ages 2-12 years.
- Scheduled to undergo radiation therapy at MD Anderson Cancer Center.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Has already completed the simulation session for radiation therapy prior to enrollment.
- Declines parental consent or, when applicable, child assent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT MD Anderson
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan L McGovern, MD, PHD
UT MD Anderson
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2026
First Posted
May 8, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2029
Last Updated
May 8, 2026
Record last verified: 2026-05